Pharmafile Logo
Pharmafocus logo
Advanced Search
roxanne_tavakkol

TKL Research hires VP of regulatory affairs

October 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roxanne Tavakkol, TKL research

Clinical research organisation TKL Research has appointed Roxanne Tavakkol to the position of vice president, regulatory and scientific services. Tavakkol …

Appointment

SHL GM Frank Isaksson signs second LOI to further increase investments in Taiwan

October 2, 2013
Manufacturing and Production auto injector, frank isaksson, pen injector, shl capacity, shl expansion

SHL Group, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, signed a second Letter of …

News
Press release

SHL Group invests in new KraussMaffei molding machines for medical device production

October 2, 2013
Manufacturing and Production auto injectors, autoinjector, pen injector, shl kraussmaffei

As SHL Group expands to provide customers with readily available services and production capabilities, the company insists on investing in …

News
Press release
Perjeta image

Perjeta becomes first approved drug for early breast cancer

October 1, 2013
Sales and Marketing FDA, Herceptin, Perjeta, Roche

Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …

News
ceravix image

MHRA: Cervarix ‘in clear’

October 1, 2013
Sales and Marketing GSK, Gardasil, MHRA, ceravix

Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …

News
Belén Garijo image

Merck makes big changes at the top

October 1, 2013
Medical Communications, Sales and Marketing Merck, Merck Serono

Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …

News
gsk image

Aspen buys GSK plant and thrombosis drugs for $1.1 billion

October 1, 2013
Manufacturing and Production, Sales and Marketing GSK, aspen

South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …

News

Cancer survival rates linked to government spending in EU

October 1, 2013
Research and Development, Sales and Marketing CDF, Cancer, EU, NICE

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …

News
boehringer image

Boehringer cancer drug impresses

October 1, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC, nintedanib

Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …

News

Eisai restates Halaven’s challenge to Roche’s Xeloda

September 30, 2013
Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …

News
oliver_brandicourt_bayer

Oliver Brandicourt joins Bayer from Pfizer

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer

Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …

Appointment

Sanofi starts work on ‘largest African facility’

September 30, 2013
Manufacturing and Production, Sales and Marketing Africa, Sanofi, algeria

Sanofi has started construction of a €70 million manufacturing facility in Algeria that will be the company’s largest site in …

News
Roche image

Roche cancer treatment shows promise

September 30, 2013
Sales and Marketing MPDL3280A, Merck Serono, NSCLC, Roche

An early-stage oncology treatment has shown encouraging results in smokers with lung cancer, Roche has said in a presentation at …

News
GSK image

GSK in Barclays deal

September 30, 2013
Sales and Marketing GSK, Zambia, barclays, csr

GlaxoSmithKline has signed a deal with banking giant Barclays in a bid to improve private sector health in Zambia, thus …

News
hunt image

Cancer Drugs Fund to run until 2016

September 30, 2013
Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP

England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …

News
dan_feldman_president_inventiv_health_europe

InVentiv Health makes strategic appointments

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv Health

Healthcare consultancy firm InVentiv Health has created two new positions
 to lead its growing business opportunities in Europe and Asia. …

Appointment
EMA building

The future of data disclosure in Europe

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, GSK, transparency

The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …

Feature

Boehringer cuts ribbon on €70m addition to Shanghai plant

September 27, 2013
Manufacturing and Production, Sales and Marketing Boehringer, China, Shanghai

Boehringer Ingelheim has officially opened the €70 million expansion of its facility in Zhangjiang, China, that is designed to triple …

News
NICE

NICE recommends ovarian cancer drug Caelyx

September 27, 2013
Sales and Marketing NICE, Yondelis, ovarian cancer

News
NHS image

Cancer Drugs Fund to stay, government to announce

September 27, 2013
Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister

The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026